Внутриплевральная фотодинамическая терапия с препаратом Фотосенс у больных с первичным и метастатическим поражением плевры, осложненным злокачественным плевритом
Диссертация
Результаты настоящего исследования внедрены в практику 1-го хирургического (торакального) отделения и отделения Реабилитации и восстановительного лечения МНИОИ им. П. А. Герцена. Практические выводы работы применяются в учебном процессе на кафедре онкологии ФППО ММА им. И. М. Сеченова, а также при проведении выездных сертификационных циклов по онкологии. Внутриплевральная пролонгированная ФДТ… Читать ещё >
Список литературы
- Акопов А. Л. Плевральный выпот при раке легкого. //Пульмонология. -2001. —Т. 11, № 4. с. 72−77.
- Бычков М. Б. Противоопухолевая химиотерапия. — М., 1996. — с. 174 — 175.
- Бычков М.А., Большакова С. А., Бычков Ю. М. Мезотелиома плевры: современная тактика лечения. //Современная онкология, т.7, № 3, 2005 (www.consilium-medicum.com/media/onkology/0503/142.shtml).
- Бычков М.Б. Лечение опухолевых плевритов делагилом. //Вопр. онкол., 1978, № 2, с.85−87.
- Возный Э.К., Добровольская Н. Ю., Большакова С. А. Специальные клинические ситуации: метастазы в легкие, плевру, печень, головной мозг.// Практическая онкология, № 2, 2000, с.38−40.
- Гетьман В.Г., Келемен И .Я., Кизименко В. М. Значение торакоскопии в дифференциальной диагностике плевритов. //Врачебное дело, 1989, № 9, с. 49—51.
- Гетьман В.Г. Клиническая торакоскопия Киев: «Здоровье», 1995. -с.206.
- Горбунова В.А., Маренич А. Ф., Голубев А. В. Современные подходы к лечению больных с местно-распространенным и метастатическим немелкоклеточным раком легкого.// Новое в терапии рака легкого. Под редакцией Н. И. Переводчиковой. Москва, 2003. — с. 69−80.
- Гутник В.В. Алимта. Новые перспективы в лечении мезотелиомы плевры. Трудный пациент, 2006, т.4, № 11.- с.35−37.
- Касьянова Т.С. Влияние радиоактивного коллоидного золота (Аи198) и химиотерапевтических препаратов (ТИО-ТЭФа, эндоксана) на динамику накопления выпота в серозных полостях при канцероматозе брюшины и плевры. Дисс. канд. мед. наук, Минск, 1968, с. 319.
- Катков А.Т. Торакоскопическое исследование при экссудативных плевритах в онкологической клинике. Дисс. канд. мед. наук, Москва, 1984, с. 191.
- Красновский А.А. Синглетный молекулярный кислород и первичные механизмы фотодинамического действия оптического излучения. // Итоги науки и техники. Сер. соврем., проблемы лазерной физики. ВНИТИ, 1990, № 3, с. 63−135.
- ЛайтР.У. Болезни плевры. М., 1986, с. 13−14.
- Лискина И.В. Опухолевые плевриты. Клшшко-морфологическая характеристика и дифференциальная диагностика. //Украинский пульмонологический журнал, 2006, № 3, с. 33−37.
- Миронов А.Ф. Фотодинамическая терапия рака новый эффективный метод диагностики и лечения злокачественных опухолей.// Соровский образовательный журнал. — 1996.- № 8.- с. 32−40.
- Морозов А.И., Меленчук И. П., Ананенков Е. Ф. и др. Терапия специфического плеврита при раке легкого. Труды МОНИКи, 1976, т.14, с.142−145.
- Переводчикова Н.И. Химиотерапия рака легкого. В кн.: Клиническая химиотерапия опухолевых заболеваний. М.: Медицина, 1976, с. 168 169.
- Полоцкий Б.Е.,. Киселевский М. В, Волков С. М. Лечение больных с опухолевым плевритом. Протоколы заседания Московского онкологического общества за 2004 г. с. 48.
- Романычев Ю.А. Дифференциальная диагностика диффузных мезотелиом плевры. Грудная хирургия, 1980, № 1, с.77−83.
- Семенков Ю.Л., Горбулин А. Е. Классификация, этиология и патогенез плевритов. Острые плевриты.- В кн.: Плевриты, Киев: Здоровье, 1983, с. 3−31.
- Соколов В.В., Филоненко Е. В., Трахтенберг А. Х. и др. Фотодинамическая терапия при первичном и метастатическом поражении плевры. Методические рекомендации, Москва, ФГУ МНИОИ им. П. А. Герцена Росздрава, 2005, с. 3−8.
- Странадко Е.Ф., Скобелкин O.K., Литвин Г. Д. и др. «Анализ непосредственных результатов фотодинамической терапии злокачественных новообразований», В сб.: Новые достижения лазерной медицины, Москва-С-Петербург, 1993, с. 218−220.
- Трахтенберг А.Х., Катков А. Т. Торакоскопичекое исследование при экссудативных плевритах в онкологической клинике. Методические рекомендации, МЗ РСФСР, Москва, 1987, с. 5−21.
- Трахтенберг А.Х., Катков А. Т. Торакоскопия с дренированием плевральной полости в лечении плеврита у онкологических больных. -Сов. медицина, 1985, № 1, с.71−75.
- Филоненко Е.В. Флуоресцентная диагностика и фотодинамическая терапия в онкологии. Дисс. на соискание уч. степени д.м.н., М.: 2006, с. 123−137.
- Фомина А.С. Клиническая картина острых экссудативных плевритов при паракостальных локализациях.- В кн.: Плевриты, Л.: Медицина, 1977, с.5−34.
- Фут X. Свободные радикалы в биологии: Пер. с англ.- М.: Мир, 1979 -т.2-с. 96−150.
- Чиссов В.И., Старинский В.В, Петрова Г. В. Состояние онкологическойпомощи населению России в 2002 году. М. — 2003 г. — с. 176.
- Aasebo U., Norum J., Sagcr G., Slordal L. Intrapleurally instilled mitoxantrone in metastatic pleural effusions: a phase II study. J Chemother- 9(2):106−11, 1997. UI: 97 319 861.
- Adjei A.A., Erlichman C., Sloan J. et al. Phase 1 and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumors. J Clin Oncol 2000- 18: 1748−57.
- Agarwal R., Athar M., Bickers D.R. et al. Evidence for the involvement of singlet oxygen in the photodestruction by chloroaluminum phthalocyanine tetrasulfonate// Biochem. Biophys. Res. Commun. 1990.- Vol. 173, № 1. -P.34−41.
- Aisner J. Current approach to malignant mesothelioma pf the pleura // Chest 1995- 107: 332S-44S.
- Alberts A.S., Falkson G., Gaedhals L. et al. Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers. J. Clin. Oncol., 1998- 6: 527−35.
- Ariel J.M., Oropeza R., Pach G.T. Intracavitery administration of radioactive isotopes in the control of effusions due to cancer. Cancer, 1966, v.19, № 8, p.1096−1102.
- Athar M., Elmets C.A., Bickers D.R. et al. A novel mechanism for the generation of superoxide anions in photosensitization //J. Clin. Invest. -1989. -Vol.83.-p. 1 137−1143.
- Aversa S., Favaretto A.G. Carboplatin and gemcitabine chemotherapy for malignant pleural mesothelioma. A phase III study of the GSTPV. Clin Lung Cancer 1999- 1: 73−5.
- Baas P., van Meerbeeclc J., Groen H., et al. Caelyx in malignant mesothelioma: a phase 11EORTC study. Ann Oncol. 2000−11:697 700. (88)
- Baxevanis C. N., Dedoussi G. V., Papadopuios N. G. et al. // Cancer. — 1994. —Vol. 74.—P. 1275— 1282.
- Bayly T.C., Kisher D.L., Sybert A. et al. Tetracycline and quinacrine in the control of malignant pleural effusions. Cancer 1978- 41:1188−92.
- Beer T.W., Shepherd P., Pullinger N.C. p27 immunostaiing is related to prognosis in malignant mesothelioma // Histopathology 2001- 38:535−41.
- Belani C.P., Einardson T.R., Arikian S.R. et al. Cost effectiveness analysis of pleurodesis in the management of malignant pleural effusion. J. Oncol. Management, 1995- 1(2):24.
- Bethune N. Pleural poudrage: New technique for deliberate production ofpleural adhesion as preliminary to lobectomy. J. Thoracic. Surg., 1935, v.4, p.251.
- Biel M. Photodynamic therapy and the treating of head and neck cancers, J. Clin. Laser. Radial. Surg., 1996- 14: 239- 44.
- Bissonnette R., Lui H. Current status of photodynamic therapy in dermatology//Dermatol. Clin. 1997. -Vol.15.- P.507−519.
- Blanc F-X., Atassi K., Bignon J., Housset B. Diagnostic value of medical thoracoscopy in pleural disease. Chest 2002- 121:1677−1683.
- Bloom A.I., Wilson M.W., Kerlan R.K. et al. Talc pleurodesis through small-bore percutaneous tubes. Cardiovasc. Intervent. Radiol.- 22(5):433−6 1999. UI: 99 431 788.
- Bonomo L., Feragalli В., Sacco R. et al. Malignant pleural disease // Eur. J. Radiol. — 2000. — Vol. 34. — P. 98−118.
- Boutin C., Frenay C., Astoul P. Endoscopic diagnosis of mesothelioma. Rev. Mal.Respir. 1999- 16:1257−62.
- Boutin C., Nussbaum E., Monnet 1. cl al. Intrapleural treatment with recombinant g-interferon in early stage malignant pleural mesothelioma // Cancer 1994- 74:2460−7.
- Boutin C., Rey F. Thoracoscopy in the diagnosis of pleural malignant mesothelioma: a prospective study of 188 consecutive patiints. Part 1: diagnosis // Cancer, 1993, vol. 72, p.389−393.
- Boutin C., Rey F., Viallet J-R. Prevention of malignant seeding after invasive diagnostic ricedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest 1995- 108: 754−8.
- Boutin C., Viallat J. R, Cargnino P., Farisse P. Thoracoscopy in malignant pleural effusions. Am Rev Resp Dis 1981- 124:588−592.
- Byrne M.J., Davidson J.A., Musk A.W. et al. Cisplatin and gemcitabine for malignant mesothelioma: A phase II study. J. Clin. Oncol., 1999- 17: 25−30.
- Camishio R.C., Gibbon J.H., Nealon T.F. Talc poudrage in the treatment of pleural effusion due cancer. Surg. clin. North. Am., 1962, v.42, p. 1521−1526.
- Chambers J.S. Palliative treatment of neoplastic pleural effusion with intercostals intubation and tale instillation. West. J. Surg., 1958, v.66, p.26−28.
- Chevertton E.B., Berenbaum M.C., Bonnee R. The effect of photodynamic therapy on normal skeletal muscle in an animal model. Laser Med. Sci. 7, 1992, p. 103−110.
- Chrysanthidis M.G., Janssen. J. P. Autofluorescence videothoracoscopy in exudative pleural effusions: preliminary results // Eur. Respir. J. 2005- 26:989−992.
- Clementsen P., Evald Т., Grode G. et al. Treatment of malignant pleural effusion: pleurodesis using a small percutaneous catheter. A prospective randomized study., Respir. Med.- 92(3): 593−6, 1998. UI: 98 357 158.
- DeLaney T.F., Sindelar W.F. et al. Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors, Int J Radiat Oncol Biol Phys 1993- 25: 445−57.
- Dooms C. et al. Treatment of malignant pleural mesothelioma with platinum-pemetrexed chemotherapy. XI WCLC, 2005, Barcelona, abs. 396.
- Dougherty T.J., Gomer C.J., Henderson B.W. et al. Photodynamic therapy // J. Natl. Cancer. Inst.-1998.- Vol. 90, № 12. P. 889−905.
- Dougherty T.J., Kaufmann J.E., Goldfarb A., Weishaupt K.R., Boyle D., г
- Mittleman A. Photoradiation therapy for the treatment of malignant tumors. Cancer Res. 1978- 38: 2628−35.
- Doukas J., Hechtman H.B., Shepro D. Vasoactive amines and eicosanoids interactively regulate both polymorphonuclear leukocyte diapedesis and albumin permeability in vitro//Microvasc. Res.- 1989.-Vol.37.- P. 125−137.
- El-Mahdi A., Levene A., Lett S. Observations and management of malignant pleural affusions in breast carcinoma. Jone Hopk. med. J, 1973, v. 132, № 1, p.44−49.
- Enzinger F.M., Weiss S.W. Synovial sarcomas and mesothelioma, in Enzinger FM, Weiss SW (eds.): Soft Tissue Tumors (ed 4).St Louis, MO, 2001- p. 755−823.
- Fingar V.H. Vascular effects of photodynamic therapy// J. Clin. Laser. Med. Surg. 1996.- Vol.14.- P.323−328.
- Fisher A.M.R., Murphree A.L., Gomer C.J. Clinical and preclinical photodynamic therapy// Lasers. Surg. Med. 1995.- Vol. 17.- P.2−31.
- Fizazi K., Ducreux M., Ruffie P. et al. Phase I dosefinding and pharmacologic study of raltitrexed combined with oxaliplatin in patients with advanced cancer. J Clin. Oncol., 2000-. 8: 2293−300.
- Foote C. S. Mechanisms of photooxygcnalion. //In Porphyrin Localization and Treatment of Tumors (Doirion D.R., Gomer C.J. egs.) New York: Alan RXiss -1984-p.3−18.
- Gellhorn A., Zaidenweber J., Ultmann J. et al. The use of Atabrine in the control of recurrent neoplastic effusions. Dis.chest., 1961, v.39, p. 165−176.
- Goey S.H., Eggermont A.M., Punt C.J. et al. Intrapleural administration of interleukin 2 in pleural mesotheliomas phase I-II study // Br J Cancer 1995−72:1283−8.
- Gomer C.J., Dougherty TJ. Determination of H- and С—hematoporphyrin derivative distribution in malignant and normal tissues// Cancer. Res. -1979.-Vol. 39.-P. 146−151.
- Govindan R., Crowley J., Schwartzberg L. et al. Phase II Trial of Bexarotene Capsules in Patients With Advanced Non-Small-Cell Lung Cancer After Failure of Two or More Previous Therapies. J. Clin. Oncol., Oct 2006- 24: 4848 4854.
- Gravelyn T.R. et al. Tetracycline pleurodesis for malignant pleural effusion: a 10C year retrospective study. Cancer 1987−59(11):1973−7.
- Green P., Heitmiller R. Thoracoscopy for Pleural Space Disease // Surg. Laparoscopy and Endoscopy, 1994, vol. 4, № 2, p. 100−102.
- Guo K., Xing Z. // Chin. Me4. J. — 1994. — Vol. 107, — P. 903 — 905.
- Harris R., Kavuru M., Rice Т., Kirbi T. The Diagnostic and Therapeutic Utility of Thoracoscopy A Review // Chest. 1995, vol. 108, p. 828−841.
- Hau Т., Forster R., Gandawidjaja L., Heemken R. Thoracoscopic Pulmonary Surgery: Idications and Results// Eur.J.Surg, 1996, vol. 162, p. 23−28.
- Hausher F.H., Yarbo J.W. Diagnosis and treatment of malignant pleural effusion. Cancer Met Rev 1987- 6(l):24−30.
- He Y.Y., An J.Y., Jiang L.J. Electric magnetic resonance and spectrophotometry evidence on the photodynamic activity of a new perylenequinonoid pigment// J. Photochem. Photobiol. 1999.- Vol. 50, № 2−3.-P.166−173.
- Henderson B.W., Dougherty T.J. How does photodynamic therapy work?// Photochem. Photobiol. 1992 — Vol.55. — P. 145−57.
- Henderson B.W., Fingar V.H. Oxygen limitation of direct tumor cell kill during photodynamic treatment of a murine tumor model/ZPhotochem. Photobiol.-1989.-Vol.49.-P.299−304.
- Herrington J.D., Gora-Harper M.L., Salley R.K. Chemical pleurodesis with doxycycline 1 g. Pharmacotherapy- 16(2):280−5 1996 UI: 96 417 682.
- Herscher L.L., Hahn S.M., Kroog G. et al. Phase I study of paclitaxel asa a radiation sensitizer in the treatment of mesothelioma and non-small lung cancer. J Clin Oncol 1998- 16: 635−41.
- Hiiierdai G. // Curr. Opin. Pulm. Med. — 1995. — Vol. 1— P. 339 — 343.
- Hori Т., Mise K., Kan N. et al. // Biotherapy. — 1992. — Vol. 5. — P. 21 — 29.
- Janne P.A. et al. An update of pemetrexed plus gemcitabine as front-line chemotherapy for patients with malignant pleural mesothelioma: a phase II clinical trial. Proc ASCQ-2005- abs. 7067.
- Janssen J. P. et al. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet. May 5, 2007- 369: 1535−39.
- Jones D. K, Earis J.E., Pearson M. G, Evans C.C. Pleural Mesothelioma presenting an apparent recurrent pulmonary embolism. Brit., J.Dis.Chest, 1981, v.75, № 4, p.403−407.
- Joseph S.F., Rosemarie M et all. Phase II Trial of Pleural Photodynamic Therapy and Surgery for Patients With Non-Small-Cell Lung Cancer With Pleural Spread. Journal of Clinical Oncology 2004: Vol 22, № ll, p. 21 922 201.
- Kato H., Okunaka Т., Shimatani H. Photodynamic therapy for early stage bronhogenic carcinoma. J CJin Laser Med Surg 1996- 14: 235−8.
- Kawada H. Evaluation of malignant pleural effusion management through pleurodesis. Lung Cancer, 1979, v.19, № 2, p.127−134.
- Kefford R.F., Woods R.L., Fox R. et al. Intracavitary adriamycin, nitrogen mustard and tetracycline in the control of malignant effusions. Med J Austral 1980−2:447−8.
- Kimel S., Tromberg B.J., Roberts W.G. et al. Singlet oxygen generation of porphyrins, chlorines and phthalocyanines// Photochem. Photobiol. 1989.-Vol. 50, № 2.-P.175−183.
- Kindler H.L. A double-blind placebo-controlled randomized phase II trial of gemcitabine and cisplatin with or without the VEGF inhibitor bevacizumab in patients with malignant mesothelioma. Curr Clin Trials Thorac Oncol 2001−4:2−4.
- Kindler H.L., van Meerbeeck J.P. The role of gemcitabine in the treatment of malignant mesothelioma. Semin Oncol 2002- 29: 70−6.
- Kindler H.L., Vogelzang N.J. Mesothelioma, in Vokes EE, Golomb HM (eds): Oncologic Therapies. Berlin, Germany, Springer-Verlang, 1999- p. 635−51.
- Kindler H.L.: Malignant pleural mesothelioma. Curr Treat Options Oncol 1: 2000- 313−26.
- Klausner J.M., Paterson IS., Kobzik L. et al. Oxygen free radicals mediate ischemia-induced lung injury// Surgery.-1989.- Vol.105.- P.192−199.
- Korbelik M. Induction of tumor immunity by photodynamic therapy// J. Clin. Laser. Me& Surg.-1996.- Vol.14. P.329−334.
- Lang Т., Riccabona G. Langseitergebnisse der intrakavitaren isotopentherapie maligner ergusse. Nucl. Med., 1974, v. 13, № 3, p.245−251.
- Law M.R., Hodson M.E., Heard B.E. Malignant Mesothelioma of the Pleura: relation between histological tupy and clinical behaviour.-Thorax, 1982, v.37,№ 11. p.810−815.
- Lee D.J., Perez S., Wang H.J. et al. Intrapleural chemotherapy for patients with incompletely resected malignant mesothelioma: the UCLA experience: J Clin Oncol 1995- 60: 262−7.
- Leff A., Hopewell P.C., Costello J. Pleural effusion from malignancy. Ann IntMed 1978−88:532−7.
- Leong S.S., Rocha Lima C.M., Sherman C.A., et al: The 1997 International Staging- System for non-small cell lung cancer: Have all the issues been addressed? Chest 115:242−248, 1999.
- Lerner H.J., Schoenfeld D.A., Martin A. et al. Malignant mesothelioma: The Eastern Cooperative Oncology Group (ECOG) experience // Cancer 1983- 52:1981−5.
- Leung J. Photosensitizers in photodynamic therapy. Semin Oncol 1994- 21: 4−10.
- Liu K., Li D., Zhang C. et al. // Med. Sci. J. — 1993. P. 186 — 189.
- Loddenkemper R., Boutin C. Thoracoscopy: present diagnostic and therapeutic indications. Eur Respir J 1993−6:1544−1555.
- Maddaus M.A., Luketich J.D. Chest wall, lung, mediastinum and pleura. In: Schwartz’s Principles of surgery. 8th edition./ Brunicardi F.C., Anderson D.K., Billiar T.R., et al (editors). 2005 McGrow Hill. Chapter 18, pp 545 610.
- Marom E.M., Patz E.F., Erasmus J.J., et al. Malignant pleural effusions: treatment with small-bore-catheter thoracostomy and talc pleurodesis. Radiology- 210(1):277−81 1999 UI: 99 103 006.
- Maroy В., Hendaoni L., Zakari S., Tubiana J.M., Hericord Ph., Khairallah S. Mesotheliome pleural a extension mediastinale predoninante revelation inhabituelle par disphagie et pneumothorax. Ann.radiol., 1981, v.24, № 8, p.661−664.
- Martinez-Moragon E., Aparicio J., Rogado M.C., et all. Pleurodesis in malignant pleural effusions: a randomized study of tetracycline versus bleomycin. Eur Respir J- 10(10):2380−3 1997 UI: 98 047 162.
- Martini N., Bains M.S., Beattie E.J. Indications for Pleurectomy in malignant effusion.- Cancer, 1975, v.35, № 3, p.734−738.
- Masotti A., Fumagalli L., Morandini G.C., Intrapleural administration of recombinant nterleukin-2 in non-small cell lung cancer with neoplastic pleural effusion, Monaldi Arch Chest Dis- 52(3):225−8 1997 UI: 97 416 203 -33.
- Matteucci P., Tresoldi M., Chies G. et al. // Tumori. — 1994. — Vol. 80. — P. 246 — 250.
- Medford A., Maskell N. Pleural effusion // Postgrad. Med. J. — 2005. -Vol. 81. P. 702−710.
- Meyer-Betz F. Untersuchungen ueber die biologische (photodynamische) Wirkung des Haematoporphyrins und anderer Derivate des Blut- und Gallenfarbstoffes. Dtsch Arch Klin Med 1913- 112: 476−503.
- Monti G., Jaurand M.C., Monnet I. et al. Intrapleural production of interleukin 6 during mesothelioma and its modulation by g-interferon treatment//Cancer Res 1994- 54:4419−23.
- Moran C.A., Wick M.R., Suster S. The role of immunohistochemistry in the diagnosis of malignant mesothelioma. Semin Diagn Pathol, Aug 2000- 17(3): 178−83.
- Nelson J.S., Liaw L.H., Orenstein A., Roberts W.G., Bems M.W. Mechanism of tumor destruction following photodynamic therapy with hematoporphyrm derivative, chlorin, and phthalocyanine// J. Natl. Cancer Inst- 1988.- V0I.8O.-P.1599−1605.
- Noppen M., Degreve J., Mignolet M., Vincken W. A prospective, randomised study comparing the efficacy of talc slurry and bleomycin in the treatment of malignant pleural effusions. Acta Clin Belg- 52(5):258−62 1997 UI: 98 150 377.
- Noppen N., Degreve J., Mignolet M., Vincken IV. // Acta Clin.Belg. — 1997. — Vol. 52. — P. 258 — 262.
- Nowak A., Byrne M., Williamson R. et al. Multicentre phase II study of cisplatin and gemcitabine (G) in malignant mesothelioma (MM). Ann Oncol 2000- 11: 109, (abstr., suppl.).
- Nseyo U., Dehaven J., Dougherty T. Photodynamic therapy (PDT) in the management of patients with resistant superficial bladder cancer: a long term experience. J Clin Laser Med Surg 1998- 16: 61−8.
- Ochsner M. Photophysical and photobiological processes in the photodynamic therapy of tumors// J. Photochem. Photobiol. В.- 1997.-Vol.39.-P. 1−18.
- Ohta Y., Shridar V., Brigt R.K. et al. VEGF, VEGF Type C, and their receptors play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumors. Br J Cancer 1999- 81: 54—61.
- Ong K.C., Indumathi V., Ong Y.Y. A comparative study of pleurodesis using talc slurry and bleomycin in the management of malignant pleural effusions. Respirology- 5(2):99−103 2000 UI: 20 350 595.
- Ong S.T., Vogelzang N.J. Chemotherapy in malignant pleural mesothelioma: A review. J Clin Oncol 1996- 14: 1007−17.
- Oral I., Kroutil M., Bayer A. Obliteration der Pleurahehlen nach wiederholten instillation von Fibrinogen im XX periment. — Z.Erkr. Atm., 1971, v.135, № 2, s. 191−194.
- Overholt BF, Panjehpour M. Photodynamic therapy for Barrett’s esophagus. Gastromtest Endosc ClinX Am 1997- 7: 207 20.
- Parulekar W., DiPrimio G., Bociek G. et al. Use of small bore versus large bore chest tubes for treatment of malignant pleural effusions (Meeting abstract). Proc Annu Meet Am Soc Clin Oncol- 16: A163 1997 UI: 97 621 036.
- Paschoalini M.S., Vargas F.S., Marchi E. et al. Prospective Randomized Trial of Silver Nitrate vs Talc Slurry in Pleurodesis for Symptomatic Malignant Pleural Effusions. Chest. August 2005 128: 684−689.
- Pass H., Donington J. Photodynamic therapy for the management of pleural malignancies. Sem Surg Oncol 1995- 11: 360−7.
- Pass H.I., Delaney Т., Tochner Z. et al. Intrapleural photodynamic therapy: a results of a phase I trial. Ann Surg Oncol 1994- 1: 28−37.
- Patz E.F., McAdams H.P., Erasmus J.J. Sclerotherapy for malignant pleural effusions: a prospective randomized trial of bleomycin vs doxycycline with small-bore catheter drainage. Chest- 113(5): 1305−11 1998 UI: 98 255 750.
- Perng R.P., Chen Y.M., Wu M.F., et al. Phase II trial of intrapleural paclitaxel injection for non-small-cell lung cancer patients with malignant pleural effusions. Respir Med- 92(3):473−9 1998 UI: 98 357 137.
- Pizzocaro G., Ravasi G.L., Bozzetti F., Vaglini M. Litalcamento del cavo pleurico nel trattamente dei versamenti neoplastici recidivanti. Tumori, 1973, v.59, № 4, p.287−293.
- Portalone L., Altieri A.M., Alimonti A et al. Phase II study: Gemcitabine plus epirucun in malignant pleural mesothelioma An AIPO Chest Oncology Study Group Trial. Ann Oncol 2000- 11: 111, (abstr., suppl.).
- Pulsiripunya C., Youngchaiyud P., Pushpakom R. et al. The efficacy of doxycycline as a pleural sclerosing agent in malignant pleural effusion: a prospective study. Respirology- l (l):69−72 1996 UI: 98 059 547.
- Raute G., Sistermann J. // Eur. J. Gynaecol. Oncol. — 1998 — Vol. 19. — P. 108 — 112.
- Rice T.W., Adelstein D.J., Kirby T.J. et al. Aggressive multimodality therapy for malignant mesothelioma. Ann Thorac Surg 1994- 58: 24−9.
- Ris H.B., Altermatt H.j., Nachbur B. et al. Intraoperative photodynamic therapy with mTHPC for chest malignancies // Lus Surg Med 1996- 18:3945.
- Roberts D.J.H., Cairnduff F., Driver I., Dixon B. et al. Tumour vascular shutdown following photodynamic therapy based on polyhaemato-porphyrin or 5-aminolaevulinic acid// Int. J. Oncol.-1994.- Vol.5.- P.763−768.
- Rogado M. C., Sanchis J., Sanchts F. et al. I I Eur. Respir. J.— 1997. — Vol. 10. —P. 2380 — 2383.
- Rosenthal I., Murali Krishna C, Riesz P. et al. The role of molecular oxygen in the photodynamic effect of phthalocyanines// Radiat. Res. 1986.- Vol. 107, № 1.-P. 136−142.
- Rusch V.W., Piantidosi S., Holmes E.C. The role of extrapleural pneumonectomy in malignant pleural mesothelioma: A lung cancer study group trial // J. Thorac Cardiovasc Surg. 1991- 102:1−9.
- Rusch V.W., Venkatraman E. The importance of surgical staging in the treatment of malignant pleural mesothelioma // J Thorac Cardiovasc Surg. 1996- 111:815−26.
- Sahn S. A. Malignant pleural effusions // Eur. Respir. Mon.— 2002. — Vol. 22. —P. 177−188.
- Sahn S.A. Malignant pleural effusion. Clin Chest Med 1985−6:113−25.
- Sahn S.A., Potts D.E. The effect of Tetracicnine on Rabbit pleura.-Amer.Rev.resp.Dis., 1978, v. l 17, № 3, p.493−500.
- Sallach S. M., Sallach J. A., Vasquez E., et al. Volume of pleural fluid required for diagnosis of pleural malignancy // Chest. — 2002. —Vol. 122. — P. 19 131 917.
- Singer J., Jones J.S., Tragerman L.J. Aseptic pleuritis experimentally Produced. J.Thorac.Surg., 1941, v. 10, p.251−280.
- Strizzi L., Catalano A., Vianile G. et al. Vascular endothelial growth factor is an autocrine growth factor in malignant mesothelioma. J Pathol 2001- 193: 468−75.
- Sugarbaker D., Richards W.G., Zellos L.S. et al. Feasibility of pleurectomy and intraoperative bicavitary hyperthermic cisplatin lavage for mesothelioma: a phase I-II study. Proc Am Soc Clin Oncol. 2003- 22:620. Abstract 2494.
- Sugarbaker D.J., Garcia J.P. Multimodality Therapy for malignant pleural mesothelioma. Chest 1997- 112:2728−58.
- Sugarbaker D.J., Garcia J.P., Richards W.G. et al. Extrapleural pneumonectomy in the multimodality therapy of the malignant pleuralmesothelioma. Results in 120 consecutive patients // Ann Surg. 1996- 224:288−96.
- Sugarbaker D.J., Heher E.C., Lee Т.Н. et al. Extrapleural pneumonectomy, chemotherapy and radiotherapy in the treatment of diffuse malignant pleural mesothelioma // J Thorac Cardiovasc Surg. 1991−102:10−5.
- Sugiura S., Ando Y., Minami H., et al: Prognostic value of pleural effusion in patients with non-small cell lung cancer. Clin Cancer Res 3:47−50, 1997.
- Suzuki H., Abo S., Kitamura M. et al. // Surg. Today. — 1993. — Vol. 23. — P. 1053 — 1059.
- Takita H., Dougherty T.J. Intracavitary photodynamic therapy for malignant pleural mesothelioma. Semin Surg Oncol 1995- 11: 368−71.
- Takita H., Mang T.S., Loewen G.M. et al. Operation and intracavitary photodynamic therapy for malignant mesothelioma: a phase II study. Arm Thorac Surg 1994- 58: 995−8.
- Tarn A.C., Lapworth R. Biochemical analysis of pleural fluid: what should we measure? Ann Clin Biochem, Jul 2001- 38:311 322.
- Taylor S.A., Hooton N.S., Macarthur A.M. Quinacrine in the management of malignant pleural effusion. Brit. J. Surg., 1977, v. 64, N1, p.52−53.
- Testa J.R., Carbone M. Mesothelioma, in Schwab M (ed): Cancer Research: An Encyclopedic Reference. Heideberg, Germany, Springer-Verlay, 2002- p. 861−5.
- Thompson R.L., Yau J.C., Donnelly R.F., et al. Pleurodesis with iodized talc for malignant effusions using pigtail catheters. Ann Pharmacother- 32(7−8):739−42 1998 UI: 98 346 065.
- Tochner A.Z., Pass H.I., Smith P.D. et al. Intrathoracic photodynamic therapy: a canine normal tissue tolerance study and early clinical experience. Lasers Surg Med 1994- 14:118−23.
- Tohda Y., Iwanaga Т., Takada M., et al. Intrapleural administration of cisplatin and etoposide to treat malignant pleural effusions in patients withnon-small cell lung cancer. Chemotherapy- 45(3): 197−204 1999 UI: 99 242 538.
- Turler A., Gawenda M., Walter M. Palliative iodized talc pleurodesis with instillation via tube thoracostomy. Support Care Cancer- 5(l):61−3 1997 UI: 97 164 278.
- Ulmann J.B., Gellhorn A. et al. The effect of Quinacrine on neoplastic effusions and certain of their enzymes. Cancer, 1963, v.16, p.283−288.
- Van Haarst J.W., Burgers J.A., Manegold C.H. et al. Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma (MPM). Lung Cancer 2000- 29: 18, (abstr., suppl.).
- Veda Y., Hirota M., Tomonaga A. et al. Treatment of malignant pleural effusions through Adriamicyne.- Jap.J.Cancer Clin., 1982, v.28, N7, p.789−793.
- Vidyasagar M.S., Ramanujam A.S., Fernandes D.J., et al. Vincristine (Vinca-alkaloid) as a sclerosing agent for malignant pleural effiisions. Acta Oncol- 38(8):1017−20 1999 UI: 20 127 521.
- Vogelzang N. et al. Long-term survival update from the randomized phase III study of pemetrexed plus cisplatin vs. cisplatin in patients with malignant pleural mesothelioma. XI WCLC, Barcelona, 2005- abs. 435.
- Vogelzang N.J., Rusthoven J., Paoletti P. et al. Phase III single-blinded study of pemetrexed + cisplatin vs. Cisplatin alone in chemonaive patients with malignant pleural mesothelioma. Proc Am Soc Clin Oncol 2002 — 21: 2a, abstr. 5.
- Vogelzang N.J., Rusthoven J.J., Symanowski J. et al. Phase III Study of Pemetrexed in Combination with Cisplatin Versus cisplatin alone in patients with malignant pleural mesothelioma // J. Clin. Oncol. 2003, 21:2636−2644.
- Wallach H.W. Intrapleural Tetracycline for malignant pleural effusions. -Chest, 1975, v.68, N4, p.510−512.
- Wallach H.W. Intrapleural tetracycline for malignant pleural effusions. Chest 1975- 68:510.1. Qfr
- Weissberg D. Talc pleurodesis: A controversial issue.- Poumon, 1981, v.37, N 5, p.291−294.
- Wieman T.J., Fingar V.H. Photodynamic therapy// Surg. Clin. North. Am.-1992.-Vol. 72.-609−622.
- Wosniak A. et al. Pemetrexed in combination with cisplatin in the treatment of chemonaive patients with malignant pleural mesothelioma. Proc ASCO 2004- abstract 7192.
- Yataco J.C., Dweik R.A. Pleural effusions: evaluation and management // Cleveland Clinic J. Med. — 2005. — Vol. 72, № 10. — P. 584−872.
- Yim A.P., Chan A.T., Lee T.W. et al. Thoracoscopic management of malignant pleural effusions. Chest- 109(5): 1234−8 1996 UI: 96 214 462.
- Zimmer P.W., Hill M., Casey K., Harvey E., Low D.E. Prospective randomized trial of talc slurry vs bleomycin in pleurodesis for symptomatic malignant pleural effusions. Chest- 112(2):430−4 1997 UI: 97 410 165. (103)
- Zoloznik A.J., Oswald S.G., Langin M. Intrapleural tetracycline in malignant pleural effusion: Cancer 1983- 51:752−5.